Lv11
26 积分 2024-11-11 加入
Bimekizumab versus Secukinumab in Plaque Psoriasis
2小时前
已完结
Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial
2天前
已完结
Safety and Efficacy of Ianalumab in Patients With Sjögren's Disease: 52‐Week Results From a Randomized, Placebo‐Controlled, Phase 2b Dose‐Ranging Study
2天前
已完结
New strategies for treating Sjogren's syndrome
4天前
已完结
Precision medicine in Sjögren's disease
4天前
已完结
Inebilizumab, a B Cell-Depleting Anti-CD19 Antibody for the Treatment of Autoimmune Neurological Diseases: Insights from Preclinical Studies
14天前
已完结
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis
14天前
已完结
Precision medicine in Sjögren's disease
18天前
已完结
Update on the pathophysiology and treatment of primary Sjögren syndrome
19天前
已完结
Modeling Combination Therapies and T Cell Exhaustion Dynamics in the Tumor Under Immune Checkpoint Blockade
24天前
已完结
皖公网安备34019202002308
